BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Operating cash flow, 2025
- $14.2B
- YoY, 2025
- −6.8%
- 5-year CAGR
- +0.1%
- 10-year CAGR
- +21.0%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $14.2B | −6.8% |
| 2024 | $15.2B | +9.6% |
| 2023 | $13.9B | +6.1% |
| 2022 | $13.1B | −19.4% |
| 2021 | $16.2B | +15.3% |
| 2020 | $14.1B | +71.2% |
| 2019 | $8.2B | +16.2% |
| 2018 | $7.1B | +34.0% |
| 2017 | $5.3B | +72.5% |
| 2016 | $3.1B | +45.3% |
| 2015 | $2.1B | −33.1% |
| 2014 | $3.1B | −11.2% |
| 2013 | $3.5B | −48.9% |
| 2012 | $6.9B | +43.4% |
| 2011 | $4.8B | +7.8% |
| 2010 | $4.5B | +10.5% |
| 2009 | $4.1B | +9.7% |
| 2008 | $3.7B | +17.6% |
| 2007 | $3.2B | — |